Advanced Oncotherapy (AVO) – Discussed by Mark Brewer – Hardman & Co Analyst

  Mark Brewer – Hardman & Co Life Sciences Analyst discusses with DirectorsTalk Advanced Oncotherapy Plc, it’s unique technology, the market size, growth drivers, key risks and an outlook for the company.